Queue
"A new way to pharmacy"
Queue's autonomous robotic pharmacy kiosk fills and verifies prescriptions with zero human handling in about 30 seconds per vial.
Queue is a robotics company that has built what it describes as the world's first fully autonomous robotic pharmacy, designed to fill and verify prescriptions without a human pharmacist or technician handling individual pills. The company's flagship product, the Queue Unit, is a self-contained kiosk that stores roughly 250 to 280 of the most commonly prescribed medications, loaded from sealed wholesale bottles. Inside the unit, computer-vision systems identify individual pills by their National Drug Code (NDC) to confirm medication identity before dispensing, and prescriptions are verified via QR code as part of the fulfillment process. Queue states the unit can fill a 60-pill vial roughly every 30 seconds, with both filling and verification occurring with what the company calls zero human involvement in the physical handling step.
Queue was founded by Nick Desai and Josh Liu. Desai is a six-time venture-backed entrepreneur who previously founded Heal, a home-visit and telehealth medical service. Liu's prior experience includes engineering and operations roles at Tesla and at Zipline, the drone-delivery logistics company, backgrounds the company has pointed to as informing the hardware and automation approach behind the Queue Unit. The company emerged from stealth mode on June 30, 2026, at which point it disclosed a $12.6 million seed funding round led by AlleyCorp, with additional participation from Riot Ventures and other investors. At the time of its public launch, Queue employed approximately 20 people and was headquartered in the Silicon Valley area, in Palo Alto, California.
The company frames its mission around addressing two linked problems in U.S. retail pharmacy: a wave of pharmacy closures that has reduced convenient access to prescription medications in many communities, and pharmacist burnout driven by high dispensing volumes and staffing shortages. By automating the mechanical dispensing and verification steps, Queue's stated goal is to let licensed pharmacists redirect their time toward patient-facing work such as medication counseling and drug-interaction checking, rather than manual pill counting. The company's brand tagline, used in its public launch materials, is "A new way to pharmacy."
As a very recently launched company, Queue has not yet published detailed technical specifications such as the physical footprint of the Queue Unit, its refill cadence, or its retail or clinical deployment partners, and independent, long-term performance data on dispensing accuracy is not yet publicly available. The company's most substantive public disclosures to date are its June 2026 stealth-exit announcement, the accompanying seed-round details, and its LinkedIn company page.
Primary type & automation activities this supplier delivers:
Queue Robotic Pharmacy Kiosk
- Launch Year: 2026
Fully autonomous kiosk that fills and verifies prescription vials from wholesale pill bottles using computer vision, in 60 seconds with zero staff.
Company Facts
Founded
2025
Primary Role
Manufacturer
Company Size
employees 10-50
Primary Region
North America
Annual Sales
-
Funding Stage
Early-Stage VC
Funding Total
-
Over 50 Robotics Firms Seek Listing on Hong Kong Stock Exchange
As of August 11, over 50 robotics and embodied intelligence companies are in various stages of listing on the Hong Kong Stock Exchange. This surge follows the recent IPO of Jing Tai Holdings, the first company under the new Chapter 18C listing rules, which cater specifically to specialized technology firms. The growing interest in the Hong Kong market highlights the rapid capitalization of robotics and related industries, with companies like Zhi Yuan Robotics aiming for a valuation of HKD 40-50 billion. The market is witnessing a shift from technology validation to mass production, as firms seek to prove their capabilities and secure large-scale orders. Looking ahead, the implementation of Chapter 18C listing rules has attracted numerous early-stage robotics companies, with 10 of the 51 firms in the queue opting for this pathway. This trend indicates a significant move towards commercialization and the potential for increased investment in the robotics sector in the coming years.
Robotics Stock Market Embodied Intelligence Technology Companies
Alipay Launches Abao Super Agent for Cars and Phones, Predicts Rapid Growth
At Alipay's inaugural AI ecosystem conference on August 17, Ant Group CEO Han Xinyi forecasted significant growth in super agents within the next 6-12 months. The company introduced its first comprehensive agent commerce foundation, focusing on the Abao super agent, which is integrated with five phone brands and 16 major car manufacturers. This development is crucial as it marks a significant step in agent commerce, with Alipay establishing a multi-agent cross-device interconnection protocol known as AHA (Agent Hub Access). The integration of Abao with various devices positions Alipay to capitalize on the growing demand for seamless commerce experiences across platforms. Looking ahead, the orders for Abao are expected to queue into the next year, indicating strong market interest and potential for expansion. No further timeline was disclosed at the time of publication.
ROBOTTODAY Weekly July 27 – 31, 2026
Your weekly robotics briefing: the US bans imports of Chinese humanoid robots, Google DeepMind unveils Gemini Robotics 2, Unitree pushes toward its Shanghai IPO, and Amazon's Zoox wins approval for paid robotaxi rides.
Kuawei Intelligence Explores Hong Kong IPO Valued Over 10 Billion Yuan
Kuawei Intelligence recently completed a Series B funding round of 1 billion yuan, achieving a post-investment valuation exceeding 10 billion yuan, making it one of the new unicorns in the sector. According to a report by Bloomberg on July 28, the company is considering an initial public offering (IPO) in Hong Kong, aiming to become the first publicly listed company focused on embodied AI. However, the IPO plans are still in preliminary discussions, with key details such as valuation and timeline yet to be finalized. This move is significant as the market for robotics and AI is rapidly evolving, with Kuawei Intelligence being a key player. The company, founded in June 2021 in Shenzhen, focuses on physical AI and world modeling, with over 70% of its workforce dedicated to research and development. The industry is witnessing intense competition, with 46 robotics-related companies currently queued for listing on the Hong Kong Stock Exchange, highlighting the urgency for firms to secure funding and market presence. Looking ahead, Kuawei aims to generate approximately 1 billion yuan in revenue in the first half of 2026, with a full-year target of 250 to 300 million yuan. The company has maintained a growth rate exceeding 100% from 2022 to 2024, with projections of 300% to 400% growth by 2026. No further timeline was disclosed at the time of publication.
Robotics AI IPO Generative Simulation Physical AI
ROBOTTODAY Weekly July 13 – 17, 2026
This week in robotics: Hyundai takes full ownership of Boston Dynamics, Xpeng targets 1,000 Iron humanoids a month, LimX Dynamics raises $200M pre-IPO, and Agility opens a Silicon Valley physical-AI hub. July 13–17, 2026.
Video: ‘World’s first’ fully robotic pharmacy automates prescription dispensing
Queue, a California-based robotics startup, has introduced the world's first fully autonomous robotic pharmacy, a groundbreaking innovation aimed at transforming the pharmaceutical industry. The unveiling took place on October 15, 2023, in San Francisco, where the company showcased its advanced technology designed to streamline medication dispensing and improve patient safety. This initiative comes in response to the growing demand for efficient healthcare solutions, particularly in light of the ongoing challenges faced by traditional pharmacies, such as staffing shortages and increased prescription volumes. By automating the pharmacy process, Queue aims to reduce human error and enhance accessibility for patients. The robotic pharmacy operates through a sophisticated system that integrates artificial intelligence and robotics, allowing it to manage inventory, fill prescriptions, and provide consultations without human intervention. This innovative approach not only promises to expedite the dispensing process but also ensures that patients receive accurate medications tailored to their needs. Queue's launch of this autonomous pharmacy marks a significant step forward in the intersection of technology and healthcare, potentially setting a new standard for pharmaceutical services in the future. As the healthcare landscape continues to evolve, the company hopes to lead the way in providing safer and more efficient solutions for patients and healthcare providers alike.
AI and Robotics
Queue raises funding to build fully autonomous pharmacy
Queue is advancing its initiative to enhance prescription access by developing fully automated pharmacies. This effort aims to serve hospitals, retail locations, and underserved communities, addressing the growing demand for efficient pharmaceutical services. Recently, the company secured funding to support the construction of these autonomous pharmacies, which are designed to streamline the dispensing process and improve patient care. By leveraging automation, Queue intends to reduce wait times and increase the availability of medications, particularly in areas where access to traditional pharmacy services is limited. The project represents a significant step towards modernizing healthcare delivery and ensuring that essential prescriptions are readily available to those in need.
Healthcare Robotics Investments News AlleyCorp pharmaceutical Queue
Beyond the Gantt Chart: How Skody AI Explains Why Orders Are Late
Skody AI goes beyond traditional APS by decomposing job lead times into specific delay causes — material waits, bottleneck queues, and off-shift gaps — giving discrete manufacturers a continuous, explainable finite-capacity schedule.
The Association for Advancing Automation Hires Aaron Prather as Director of Market Intelligence
Aaron Prather joins the Association for Advancing Automation (A3) as Director of Market Intelligence, bringing expertise from FedEx and ASTM International to drive robotics industry insights.
10 Best Traffic Management and Queueing Solutions for High-Traffic Websites in 2026
A sudden surge in web traffic led to the collapse of a server, causing significant disruptions for users and raising concerns among the technical team. The incident unfolded as analytics data displayed alarming spikes, prompting immediate panic and a flurry of communication via Slack among staff members. Concurrently, social media platforms, particularly X (formerly Twitter), saw a growing backlash from frustrated users. This situation underscores the critical importance of effective traffic management strategies to prevent such failures in the future. The incident serves as a reminder of the challenges faced by online services in handling unexpected demand and the need for robust infrastructure to maintain user satisfaction.
Business Software Akamai automation news cloud infrastructure Cloudflare
Unitree's IPO Review: What It Means for China's Humanoid Robot IPO Landscape
On 1 April 2026, China's Securities Association (CSAC) randomly selected Unitree Robotics for a mandatory on-site IPO inspection — just 12 days after its STAR Market application was accepted. The event has generated significant market commentary. This analysis examines the regulatory context, what the inspection actually means, the four core controversies in Unitree's prospectus, and the implications for competing humanoid robot companies pursuing public listings.
SpaceX S-1 Flags Orbital AI Data Centres as High-Risk, Early-Stage Ventures
SpaceX's confidential IPO filing frames orbital AI data centres as early-stage and commercially unproven, flagging Starship dependency and extreme space environment risks as key uncertainties.
